Advancing Knowledge. Enhancing Care.
Advancing Knowledge. Enhancing Care.

Psoriasis News

the latest news from ipc, industry and others

IPC forum explores biosimilars at international conference

In July, IPC convened a Hot Topics Roundtable discussion on biosimilars, preceding the International Federation of Psoriasis Association’s 5th World Psoriasis & Psoriatic Arthritis Conference in Stockholm, Sweden. IPC councilors, staff, invited speakers, and corporate partners attended the full-day roundtable program, which focused on interchangeability, physician education, and integration of biosimilars into clinical practice. Presentations were made by industry partners and regional thought leaders, highlighting a variety of perspectives on biosimilars in practice. Following the presentations, IPC members discussed current perspectives and data in view of updating IPC’s position on biosimilar issues. Program chairs for this session were IPC councilors Arnon Cohen, Israel, and Jay Wu, United States. Invited speakers were Gillian Woolett, senior vice president of the Washington, DC-based advisory services firm Avalere Health, and Dr. Jonathan Kay, professor of medicine and director of clinical research, rheumatology division, at the University of Massachusetts, Worcester. Additional presentations were made by IPC councilors Matías Maskin, Argentina and IPC Board Member Lluís Puig, Spain.

Stay informed

Join the email list to receive the latest information on psoriasis meetings, manuscripts and research.

now available

COVID-19 Psoriasis Resource Center

Information from around the world on psoriasis and coronavirus to assist dermatologists and the patients they serve

explore now


on SARS-CoV-2 Vaccines and Psoriasis

Six key take-aways that physicians and other healthcare practitioners should consider when administering the SARS-CoV-2 vaccine to psoriasis patients.


We use cookies on this site to enhance your online experience. By continuing to use this site, you agree to accept cookies.